The MedIQ Series A closed in May 2025 with $6 million from Gulf investors, making it one of the biggest equity raises in Pakistan’s startup scene that year and a clear signal that disciplined, infrastructure-first healthtech can still pull serious capital even when broader funding stays tight. While most of Pakistan’s startup world spent 2024 and early 2025 chasing smaller cheques, MedIQ founder Dr. Saira Siddique built something investors in Doha and Riyadh were willing to bet on.
What Is MedIQ and Who Backed the MedIQ Series A?
MedIQ raised $6M in a Series A funding round led by Qatar’s Rasmal Ventures and Saudi Arabia’s Joa Capital, with follow-on investment from existing backers. The funding round is described as one of the largest in the history of the Kingdom’s health tech sector.
Founded in 2020 by physician-turned-entrepreneur Dr. Saira Siddique, MedIQ is building what it calls the “operating system for healthcare” in the MENAP region, covering the Middle East, North Africa, Afghanistan, and Pakistan.
Its founder started the company following her personal experience with Pakistan’s “fragmented and inaccessible” healthcare system. That personal pain point turned into a product with real traction. Since entering Saudi Arabia in 2023, MedIQ has served over 10 million patients and become EBITDA-positive. Reaching profitability before closing a Series A is rare for any startup, and it almost certainly made the difference when sitting across from Gulf investors.
What the Platform Actually Does
MedIQ offers a digitally integrated hybrid healthcare ecosystem for B2B and B2B2C clients, combining telehealth, e-pharmacy, AI-powered facility digitisation, and back-office automation for insurers. That is a very different model from a simple doctor-booking app. Instead of selling directly to patients one appointment at a time, MedIQ sells infrastructure to hospitals, insurers, and government agencies, then reaches patients through those institutions.
The company offers end-to-end solutions including EHR, revenue cycle management, telehealth, e-pharmacy, and AI-powered decision support. Building all of this in Pakistan first, where margins are thin and infrastructure is patchy, gave MedIQ a tested tech stack that now works well in the Gulf’s bigger, better-funded healthcare market.
Why This Matters for Pakistan’s Startup Ecosystem
When you look at the full picture of Pakistan startup funding in 2025, the MedIQ Series A stands out sharply. Based on announcements, Pakistani startups raised approximately $36.6 million in equity capital across 10 rounds in 2025, rising from $22.5M in 2024, even as the number of deals edged slightly lower. Healthtech emerged as the second most active sector by both equity value and number of deals, with MedIQ’s $6M Series A being among the largest disclosed equity raises of the year.
For more context on where Pakistan sits globally, see our earlier look at Pakistan’s startup ecosystem ranking and what it will take to produce the country’s first unicorn.
Azfar Hussain, Project Director at the National Incubation Center Karachi, said 2025 marked a period of correction and maturity for Pakistan’s startup ecosystem, noting that capital became more selective, filtering out hype-driven ventures while strengthening founders focused on solving real-world problems. MedIQ fits that description exactly.
There is also a broader pattern at play. Female founders and mixed-gender teams remained central to the 2025 deal flow, with female-founded and co-founded startups accounting for eight of the 11 disclosed deals. Funding to female-founded or co-founded startups nearly doubled, increasing from $5.5 million in 2024 to $10.1 million in 2025. MedIQ, led by Pakistan’s first solo female healthtech founder, was the anchor deal in that shift.
What Healthtech Got Right That Others Did Not
The key difference between MedIQ and many Pakistan startups that struggled to raise in 2024 and 2025 comes down to three things: a B2B revenue model, a regional expansion strategy, and a clear path to profitability. Consumer-facing apps burn cash to acquire individual users. MedIQ signed hospitals and insurers, which meant bigger contracts, stickier relationships, and a business that could reach EBITDA-positive before asking for more money.
With learnings from implementation in Pakistan, a tested tech stack, subject matter expertise, and on-ground presence in Saudi Arabia, MedIQ gained strong traction clearly indicating product market fit not only for KSA but similar GCC countries. Using Pakistan as a training ground, then moving into a wealthier market with that proven product, is a playbook more Pakistani startups should consider.
The funding will be used to scale operations across Saudi Arabia’s SAR 7.2 billion healthtech market, enhance its tech stack, and support expansion into Qatar and neighbouring Gulf countries. This latest funding round brings MedIQ’s total investment to $9.8 million.
The Digital Health Gap MedIQ Is Trying to Fix
Back home in Pakistan, the problem MedIQ was built to solve remains very real. Approximately 63% of rural residents have limited access to medical services, and Pakistan’s doctor-to-patient ratio stands at 1:1300, significantly higher than the WHO’s recommended ratio of 1:1000. Overcrowded public hospitals, long travel distances, and the high cost of care often delay treatment or discourage people from seeking help altogether.
MedIQ is currently active in more than 50 Pakistani cities and is now looking beyond its borders, eager to use this fresh injection of cash to expand further into Saudi Arabia and into neighbouring Qatar and other Gulf nations. The Gulf revenue, in theory, funds the infrastructure that keeps services affordable in Pakistan. That loop matters.
The MedIQ Series A is therefore not just a fundraising headline. It is proof that a Pakistani healthtech company can build something worthy of Gulf capital, reach EBITDA-positive, and still keep its roots in a country that badly needs better digital health access. The Series A is a strong signal of investor confidence in the broader health tech opportunity in the region, an estimated $2 billion market in Saudi Arabia alone.
Frequently Asked Questions
How much did MedIQ raise in its Series A?
MedIQ raised $6 million in its Series A round, closed in May 2025. The round was led by Rasmal Ventures from Qatar and Joa Capital from Saudi Arabia, with continued support from earlier investors. This brings MedIQ’s total funding to $9.8 million across three rounds.
Who founded MedIQ?
MedIQ was founded by Dr. Saira Siddique, a physician-turned-entrepreneur, after surviving a personal health crisis that exposed the inefficiencies in Pakistan’s fragmented healthcare system. She is also recognised as Pakistan’s first solo female healthtech founder.
What does MedIQ actually do?
MedIQ is a digital health platform that connects patients, hospitals, insurers, and government agencies. Its services include electronic health records, telehealth consultations, e-pharmacy, physiotherapy booking, home nursing, and AI-powered decision tools for healthcare providers. It works on a B2B and B2B2C model, meaning it mostly sells to organisations rather than directly to individual users.
Why is the MedIQ Series A significant for Pakistan?
It was one of the single largest equity deals in Pakistan’s startup ecosystem in 2025, at a time when funding was selective and cautious. It also showed that a company built in Pakistan, solving a Pakistan-specific problem, could win Gulf investment at Series A scale by proving a real business model first rather than chasing growth at any cost.